Skip to main content
Skip to content
Case File
efta-01521908DOJ Data Set 10Other

EFTA01521908

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01521908
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL ACCT For the Period 12/1/13 to 12/31/13 Equity Summary Asset Categories Beginning Market Value Ending Market Value Change In Value Current Allocation US Large Cap Equity 459317.45 511.226.25 51.908.80 10% US Small/Mid Cap Equity 16110.00 14220.00 (1.890.00) 1% Non-US Equity 160.27 169.41 9.14 1% Preferred Stocks 443,979.00 442,270.00 (1,709.00) 6% Concentrated & Other Equity 164,904.00 165,248.00 342.00 3% Total Value $1,084,470.72 $1,133,131.66 $48,680.94 23% Market Value/cost Current Period Value Marko! \/a'ue 1,133,131.66 Tar. Cost 1,034,682.24 Unrealized Gain aos'a 98,449.42 ESti mated Annual Income 48,356.57 Accrued Di. dends 3,090.09 Yield 4.25% Equity Detail Asset Categories NOtuUS Equity US Striailitint Cap Equity Concentrated 6 Other EquRy Equity as a percentage of your portfolio - 23 % US Wye Cep Equity Pretoria stocks Adjusted Tax Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity APACHE CORP 037411-10-5 APA J.P.Morgan 85.94 95.000 6164.30 11403.30 (3.239.00) 76 00 0 93 nr. Page 5 of 31 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00049354 SDNY_GM_00318552 EFTA01521908

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.